Prasugrel as antiplatelet therapy in patients with acute coronary syndromes or undergoing percutaneous coronary intervention.
Fletcher
Barbara
B
Brooks College of Health, School of Nursing, University of North Florida, Jacksonville, Florida 32250, USA. bjflet@att.net
Thalinger
Karen K
KK
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000451:nursing* / Q000503:physiopathology / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D010879:Piperazines; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine